Company: LNAI
Filing Date: 2025-12-03
Form Type: 424B5
Source: 0001731122-25-001626
Chunk: 4

Company: Lunai Bioworks Inc.
Filing Date: 2025-12-03
Form: 424B5
Chunk 4
---
 from the information
contained in the accompanying prospectus, you
should rely on the information set forth in this prospectus supplement.

This prospectus supplement
is part of a registration statement that we originally
filed with the Securities and Exchange
Commission (the “SEC”) utilizing a
“shelf” registration process on October 30, 2024 and declared
effective by the SEC on November 6, 2024. Under
the shelf registration process, from time to time,
we may offer and sell any of the securities described
in the accompanying prospectus separately or together
with other securities described therein.

You
should rely only on the information contained
or incorporated by reference in this prospectus
supplement and the accompanying prospectus. Neither we nor Dawson James
has authorized anyone else to provide you with
information that is in addition to or different
from that contained or incorporated by reference in this prospectus supplement
and the accompanying prospectus, along with
the information contained in any permitted
free writing prospectuses we have authorized for use in
connection with this offering.

We
are offering to sell, and seeking offers to buy,
shares of our Common Stock only in jurisdictions where offers
and sales are permitted. The information contained
in this prospectus supplement and the accompanying
prospectus is accurate only as of the date
of this prospectus supplement or the date of the
accompanying prospectus, as applicable, and the
information in the documents incorporated by reference
in this prospectus supplement and the accompanying prospectus
is accurate only as of the date of those respective documents,
regardless of the time of delivery of this prospectus supplement
and the accompanying prospectus or of any sale
of our Common Stock. Our business, financial condition, results of operations and
prospects may have changed since those dates.
It is important for you to read and consider all information contained
or incorporated by reference in this prospectus supplement and the
accompanying prospectus in making your investment
decision. You should read both this
prospectus supplement and the accompanying prospectus,
as well as the documents incorporated by reference into this prospectus
supplement and the accompanying prospectus and
the additional information described under “Whe re You Can Find Mo re Information” and
“Incorporation of Documen ts by Refe rence”
in this prospectus supplement and in the accompanying prospectus,
before investing in our Common Stock.

We
further note that the representations,